Pancreatic Cancer Mutations

Pancreatic cancer vaccine shows promise

Vaccine targeting pancreatic cancer shows promise in new study of clinical trial

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.

Medical Xpress · 12h

Vaccine shows promise for pancreatic cancer, study finds

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.

Interesting Engineering on MSN · 1d

New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a critical time,

NBC News on MSN · 2d

mRNA vaccines show promise against pancreatic cancer in early trial

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published Wednesday.

FOX News on MSN · 1d

Experimental vaccine for common cancer shows potential in clinical trial

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.

pancan1d

Research Spotlight

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...

Cure Today10d

Explaining KRAS Mutations For Patients With Colorectal Cancer

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.

Can mRNA vaccines help in the fight against pancreatic cancer?

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

Nature3d

Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer

A multicentre randomized trial of bespoke RNA vaccines in pancreatic cancer (NCT05968326) is under way to further test this approach. • Cancers with few mutations, such as pancreatic cancer ...

southcarolinapublicradio11d

Pancreatic cancer research

Dr. Hawkins: So, there's a lot of new things being developed to try and detect and screen for pancreatic cancer. These are ...

Metastatic Pancreatic Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results